BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28562517)

  • 1. Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
    Kaneva K; Chow E; Rosenfield CG; Kelly MJ
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e259-e262. PubMed ID: 28562517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Crohn's disease, iron deficiency anemia and intravenous iron treatment: a follow-up study.
    Valério de Azevedo S; Maltez C; Lopes AI
    Scand J Gastroenterol; 2017 Jan; 52(1):29-33. PubMed ID: 27576956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of Iron Deficiency Anemia With Intravenous Iron Sucrose in Children With Inflammatory Bowel Disease.
    Danko I; Weidkamp M
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):e107-e111. PubMed ID: 27540710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition.
    Michaud L; Guimber D; Mention K; Neuville S; Froger H; Gottrand F; Turck D
    Clin Nutr; 2002 Oct; 21(5):403-7. PubMed ID: 12381338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
    Mantadakis E; Tsouvala E; Xanthopoulou V; Chatzimichael A
    World J Pediatr; 2016 Feb; 12(1):109-13. PubMed ID: 25754747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose.
    Grim K; Lee B; Sung AY; Kotagal S
    Sleep Med; 2013 Nov; 14(11):1100-4. PubMed ID: 23993871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE; Plantz K; Maxwell EC; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
    Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
    Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
    Shi Q; Leng W; Wazir R; Li J; Yao Q; Mi C; Yang J; Xing A
    Gynecol Obstet Invest; 2015; 80(3):170-8. PubMed ID: 25824489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia.
    Wall GC; Pauly RA
    Am J Health Syst Pharm; 2008 Jan; 65(2):150-3. PubMed ID: 18192261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness to parenteral iron therapy in children with oral iron-refractory iron-deficiency anemia.
    Akin M; Atay E; Oztekin O; Karadeniz C; Karakus YT; Yilmaz B; Erdogan F
    Pediatr Hematol Oncol; 2014 Feb; 31(1):57-61. PubMed ID: 24087940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intermittent iron treatment of two- to six-year-old Jordanian children with iron-deficiency anemia.
    Faqih AM; Kakish SB; Izzat M
    Food Nutr Bull; 2006 Sep; 27(3):220-7. PubMed ID: 17542112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Derman R; Roman E; Modiano MR; Achebe MM; Thomsen LL; Auerbach M
    Am J Hematol; 2017 Mar; 92(3):286-291. PubMed ID: 28052413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia.
    El Khouly NI
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):967-971. PubMed ID: 27269410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia.
    Pfenniger A; Schuller C; Christoph P; Surbek D
    J Perinat Med; 2012 Apr; 40(4):397-402. PubMed ID: 22752771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral iron sucrose in iron deficiency anaemia of paediatric chronic kidney disease.
    Moorani KN; Asim S
    J Ayub Med Coll Abbottabad; 2011; 23(3):47-50. PubMed ID: 23272434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron.
    Powers JM; Shamoun M; McCavit TL; Adix L; Buchanan GR
    J Pediatr; 2017 Jan; 180():212-216. PubMed ID: 27776750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, therapeutic effectiveness, and cost of parenteral iron therapy.
    Asma S; Boga C; Ozdogu H
    Int J Hematol; 2009 Jul; 90(1):24-27. PubMed ID: 19495930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltose.
    Schatz U; Illigens BM; Siepmann T; Arneth B; Siegert G; Siegels D; Heigl F; Hettich R; Ramlow W; Prophet H; Bornstein SR; Julius U
    Atheroscler Suppl; 2015 May; 18():199-208. PubMed ID: 25936327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.